Agenda & Speakers
Agenda & Speakers
TMU Clinical Trial Insight 2025 — Pathway to DCT in Taiwan
| 08:30-09:00 | Registration |
| 09:00-09:10 | Opening Remarks Kevin, Ming-Hsun Liu, Counselor, Ministry of Health and Welfare Mai-Szu Wu, President, Taipei Medical University |
| 09:10-09:15 | Group Photo |
Session 1 Global Frontiers of DCT: Asian Leaders in Action | |
| Moderator: | Pei-Shan Tsai, Vice President, Taipei Medical University Jiunn-Horng Kang, Dean, College of Biomedical Engineering, Taipei Medical University |
| 09:15-09:35 | Fully Decentralized Clinical Trials in Oncology【Slides】 Kenichi Nakamura Chief, Department of International Clinical Development, National Cancer Center Hospital JAPAN |
| 09:35-09:55 | Decentralized Clinical Trial in Korea Seunghoon Han Vice Dean of Student Affairs, College of Medicine, the Catholic Univ. of Korea |
| 09:55-10:15 | Strategic Practices of Kyushu University in Advancing Decentralized Clinical Trials【Slides】 Kouta Funakoshi Assistant Professor, Kyushu University Hospital |
| 10:15-10:30 | Break |
| 10:30-10:50 | Decentralized Trials in Taipei Medical University【Slides】 Chaur-Jong Hu Dean, College of Medicine, Taipei Medical University |
| 10:50-11:10 | Accelerating DCT in Asia/Taiwan: CRO Strategies for Patient-Centric & Compliant Execution Mark Harvill Chief Executive Officer, Avance Clinical |
| 11:10-11:30 | Discussion |
| 11:30-12:00 | First Floor Exhibition Guide |
| 12:00-13:30 | Luncheon |
Session 2 Regulations Meet Innovation: Enabling DCT through Policy and Ethics | |
| Moderator: | Chung-Hsi Lee, Dean, College of Humanities and Social Sciences, Taipei Medical University Mei-Yi Wu, Vice Superintendent, Taipei Medical University Shuang Ho Hospital |
| 13:30-13:55 | Emerging Trends in Clinical Trials — Regulations on Decentralized Clinical Trials【Slides】 Pin-Tzu Chen Associate Reviewer, Taiwan Food and Drug Administration, Ministry of Health and Welfare |
| 13:55-14:20 | Enhancing Taiwan’s Decentralized Clinical Trial Framework and Practice: Insights from International Experience Cheng-Yen Lu Legal Researcher, Science & Technology Law Institute, Institute for Information Industry |
| 14:20-14:30 | Ethical Considerations of Decentralized Clinical Trials: Perspectives on Subject Safety and Rights【Slides】 Wan-Zhen Huang Director, JIRB Administration Section, Taipei Medical University |
| 14:30-14:45 | Discussion |
| 14:45-15:00 | Break |
Session 3 Bringing DCT Home: Real-World Execution across the Ecosystem | |
| Moderator: | Chen-Yuan Chiang, Vice Superintendent, Taipei Municipal Wanfang Hospital Chun-Yao Huang, Vice Superintendent, Taipei Medical University Hospital |
| 15:00-15:15 | Decentralized Clinical Trial and eConsent Ariel Hsu Associate Director, Investigator Engagement, Eli Lilly and Company (Taiwan), Inc. |
| 15:15-15:30 | Last-Mile Logistics in DCT: Critical Link Between Trial and Patient【Slides】 Fannie Lai Vice President, Head of Sales North Asia, Marken, UPS Healthcare Precision Logistics |
| 15:30-15:45 | 建構分散式虛擬醫院攻防演練平台【Slides】 Shih-Hao Chang Associate Professor, Department of Computer Science and Information Engineering, National Taipei University of Technology |
| 15:45-16:00 | Localized Implementation of Decentralized Clinical Trials【Slides】 Chien-Ju Kuo Director, Joint Clinical Research Center, Office of Human Research, Taipei Medical University |
| 16:00-16:05 | Industrial Perspectives Tina Sun President, Taiwan Clinical Trial Consortium |
| 16:05-16:20 | Discussion |
| 16:20-16:30 | Closing Remark Chun-Jen Huang, Dean, Office of Human Research, Taipei Medical University |
Virtual Session | |
Practical Experience of Promoting Decentralized Clinical Trials in Japan by DCT Japan Shinsuke Muto President, DCT Japan Co., Ltd. | |
Ren-Guey Lee Distinguished Professor, Department of Electronic Engineering, National Taipei University of Technology | |
